| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8525369 | Biomedicine & Pharmacotherapy | 2018 | 8 Pages |
Abstract
ENO1 functions as an oncogene in RB and inhibiting ENO1 by miR-22-3p suppresses the proliferation of RB cell lines. miR-22-3p/ENO1 pathway may serve as a novel target in RB.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yan Liu, Huanhuan Li, Yao Liu, Zhichao Zhu,